Retinal vasoproliferative tumors in patients with neurofibromatosis: An analysis of 5 patients
β Scribed by Shields, Jerry A.; Pellegrini, Marco; Kaliki, Swathi; Shields, Carol L.
- Book ID
- 123485968
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 44 KB
- Volume
- 17
- Category
- Article
- ISSN
- 1528-3933
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Five percent of individuals with neurofibromatosis type 1 (NF1) present with congenital long bone pseudarthrosis (PA). In large series, 50-80% of patients with congenital long bone PA also have NF1. Very little information exists on the natural history and pathogenesis of PA in NF1. This report
The neurofibromatosis type I gene encodes a protein, neurofibromin, which may function as a tumor suppressor gene product. Recent studies have demonstrated loss of neurofibromin in tumors from NF I and non-NF I patients, including neurofibrosarcomas. neuroblastomas and malignant melanomas. Since ne
Neurofibromatosis type 1 (NF1) is characterized by clinical features that primarily affect tissues derived from the neural crest (neurofibromas, caf~-aulait macules). Because aberrant regulation of alternative splicing in the NF1 gene transcript may be of functional significance, cultured melanocyte